HIV Diagnostics Market Analysis, Segmentation and Application up to 2025
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> <strong>Analysis</strong>, <strong>Segmentation</strong> <strong>and</strong> <strong>Application</strong><br />
<strong>up</strong> <strong>to</strong> <strong>2025</strong><br />
“The human immunodeficiency virus (<strong>HIV</strong>) leads <strong>to</strong> Acquired<br />
Immuno Deficiency Syndrome (AIDS). <strong>HIV</strong> attacks the immune<br />
system; thereby making one vulnerable <strong>to</strong> hoards of diseases.<br />
The fac<strong>to</strong>rs that propel the growth of the <strong>HIV</strong> <strong>Diagnostics</strong> industry<br />
include growing number of blood transfusions.”<br />
The <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> is anticipated <strong>to</strong> reach USD 4.48 billion by 2022. The human immunodeficiency<br />
virus (<strong>HIV</strong>) leads <strong>to</strong> Acquired Immuno Deficiency Syndrome (AIDS). <strong>HIV</strong> attacks the immune system; thereby<br />
making one vulnerable <strong>to</strong> hoards of diseases. The fac<strong>to</strong>rs that propel the growth of the <strong>HIV</strong> <strong>Diagnostics</strong> industry<br />
include growing number of blood transfusions <strong>and</strong> blood donations, prevalence of <strong>HIV</strong>/AIDS worldwide,<br />
assistance offered by point-of-care instruments & kits, <strong>and</strong> growing consciousness about <strong>HIV</strong>/AIDS <strong>and</strong> rising<br />
administration initiatives.<br />
On the other h<strong>and</strong>, there are fac<strong>to</strong>rs that may hamper the growth of the market including absence of acceptable<br />
testing labs, <strong>and</strong> restrictions of labora<strong>to</strong>ry-based testing. <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> is anticipated <strong>to</strong> grow at a<br />
significant CAGR of 9.5% in the <strong>up</strong>coming period as the scope, product types, <strong>and</strong> its applications are increasing<br />
across the globe.<br />
<strong>HIV</strong> <strong>Diagnostics</strong> industry may be explored by Product type, end user, test type, <strong>and</strong> geography. The market may<br />
be explored by product type as Instruments, Software <strong>and</strong> Services, Consumables, Kits, Assay, <strong>and</strong> Reagents,<br />
<strong>and</strong> the other Consumables. The “Consumables” segment led the market in 2016 <strong>and</strong> is anticipated <strong>to</strong> maintain<br />
its dominance by <strong>2025</strong> due <strong>to</strong> rising occurrence of <strong>HIV</strong>/AIDS, <strong>and</strong> growing enterprises from governments <strong>to</strong> fight<br />
<strong>HIV</strong>/AIDS.<br />
Get a Sample Copy of This Report @<br />
https://www.millioninsights.com/industry-reports/hiv-diagnostics-market/request-sample
The <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> could be explored based on end users as Hospitals, <strong>Diagnostics</strong> Labora<strong>to</strong>ries, Home<br />
care settings, Blood banks, <strong>and</strong> Others (Gene bank, cell bank, pharma companies, <strong>and</strong> Biotechnology). The<br />
“Diagnostic Labora<strong>to</strong>ries” segment led the market in 2016 <strong>and</strong> is anticipated <strong>to</strong> maintain its dominance by 2022<br />
owing <strong>to</strong> technological developments of diagnostics labora<strong>to</strong>ries, <strong>and</strong> high investment, <strong>and</strong> increasing<br />
consciousness of <strong>HIV</strong>/AIDS.<br />
The market may be analyzed by test type as Tests for Viral Identification, Antibody Test, Viral Load Tests, Tests<br />
for Early Infant Diagnosis, <strong>and</strong> CD4 Tests. The “Antibody Tests” segment led the <strong>HIV</strong> <strong>Diagnostics</strong> industry in 2016<br />
<strong>and</strong> is anticipated <strong>to</strong> maintain its dominance by 2022. The fac<strong>to</strong>rs that attribute <strong>to</strong> the growth of market include<br />
consciousness about <strong>HIV</strong>, growing technological developments in <strong>HIV</strong> diagnosis.<br />
Browse Full Research Report @<br />
https://www.millioninsights.com/industry-reports/hiv-diagnostics-market<br />
North America accounted for the major share of the <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong> Size in 2017 <strong>and</strong> will continue <strong>to</strong><br />
lead in the forecast period. The fac<strong>to</strong>rs that could be attributed <strong>to</strong> the growth include increasing awareness<br />
about <strong>HIV</strong>, high occurrence <strong>and</strong> prevalence of <strong>HIV</strong>/AIDS, <strong>and</strong> rising administration initiatives <strong>and</strong> growing blood<br />
donations.<br />
Some of the key players that fuel the growth of the <strong>HIV</strong> <strong>Diagnostics</strong> industry comprise Abbott Healthcare, Alere<br />
Inc., Brsi<strong>to</strong>l-Myers Squibb, Abbvie Inc., Gilead Sciences, Janssen Therapeutics, Merck & Co. Inc, BD Biosciences,<br />
bioMerieux, VIIV Healthcare, Beckman Coulter, Sysmex, Partec, Qiagen, Apogee Flow Systems, Zyomyx Inc.,<br />
Roche <strong>Diagnostics</strong>, Mylan Inc., Siemens Healthcare, <strong>and</strong> PointCare Technologies Inc. The leading companies are<br />
taking <strong>up</strong> partnerships, mergers <strong>and</strong> acquisitions, <strong>and</strong> joint ventures in order <strong>to</strong> boost the inorganic growth of<br />
the industry.<br />
<strong>Market</strong> Segment:<br />
<strong>HIV</strong> <strong>Diagnostics</strong> Product Outlook (Revenue, USD Million, 2012 - 2022)<br />
• Antibody Tests<br />
• <strong>HIV</strong>-1 Screening Tests<br />
• ELISA/EIA<br />
• Home Access Dried Blood Spot<br />
• Rapid Tests (Dot plot, Agglutination Tests)<br />
• <strong>HIV</strong>-1 Antibody Confirma<strong>to</strong>ry Tests
• Western Blot Test<br />
• Indirect Immunofluorescent Antibody Assay (IFA)<br />
• Line Immunoassay<br />
• RadioImmunoPrecipitation Assay (RIPA)<br />
• <strong>HIV</strong>-2 & Gro<strong>up</strong> O Diagnostic Tests<br />
• Blood Antibody Tests<br />
• Dried Blood Spot (DBS) Test<br />
• Others <strong>and</strong> (Oral, Urine)<br />
• Viral Identification Assays<br />
• P24 Antigen Test<br />
• Qualitative PCR Tests<br />
• Viral Culture<br />
• CD4 Testing<br />
• Viral Load Testing<br />
• Early Infant <strong>Diagnostics</strong><br />
<strong>HIV</strong> <strong>Diagnostics</strong> Regional Outlook (Revenue, USD Million, 2012 - 2022)<br />
• North America<br />
• U.S.<br />
• U.S. <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong>, by Product<br />
• Canada<br />
• Canada <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong>, by Product<br />
• Europe<br />
• Germany
• Germany <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong>, by Product<br />
• UK<br />
• UK <strong>HIV</strong> <strong>Diagnostics</strong> <strong>Market</strong>, by Product<br />
• Asia Pacific<br />
• Latin America<br />
• MEA<br />
See More Reports of this Category by Million Insights @<br />
https://www.millioninsights.com/industry/healthcare<br />
Get in <strong>to</strong>uch<br />
At Million Insights, we work with the aim <strong>to</strong> reach the highest levels of cus<strong>to</strong>mer satisfaction. Our<br />
representatives strive <strong>to</strong> underst<strong>and</strong> diverse client requirements <strong>and</strong> cater <strong>to</strong> the same with the<br />
most innovative <strong>and</strong> functional solutions.<br />
Contact Person:<br />
Ryan Manuel<br />
Research S<strong>up</strong>port Specialist, USA<br />
Email: ryan@millioninsights.com<br />
Global Headquarters<br />
Million Insights<br />
Fel<strong>to</strong>n Office Plaza 6265 Highway 9 Fel<strong>to</strong>n, California 95018, United States<br />
Phone: 1-408-610-2300<br />
Email: sales@millioninsights.com<br />
Asia Pacific<br />
Million Insights<br />
Office No. 302, 3rd Floor, Manikch<strong>and</strong> Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016<br />
India<br />
Phone: 91-20-65300184
Change language